Alexion Pharmaceuticals

• Archives
• Highlights
• Media Kit
• Inquiries

Press Releases

• Thursday, May 10, 2012

  Alexion to Present at Bank of America Merrill Lynch 2012 Health Care Conference

• Monday, April 30, 2012

  Alexion to Present at Deutsche Bank Securities 37th Annual Health Care Conference

• Tuesday, April 24, 2012

  Alexion Reports First Quarter 2012 Results

• Tuesday, April 10, 2012

  Alexion Pharmaceuticals to Report First Quarter 2012 Results on Tuesday, April 24, 2012

• Thursday, March 29, 2012

  Asfotase Alfa Significantly Decreased TNSALP Substrates and Improved 6-Minute Walk Test Results in Adolescents and Adults with Hypophosphatasia (HPP)

• Wednesday, March 7, 2012

  CORRECTING and REPLACING New England Journal of Medicine Publishes Data from Phase 2 Study of Asfotase Alfa in Life-Threatening Hypophosphatasia

• Tuesday, March 6, 2012

  Alexion to Present at Barclays Capital Global Healthcare Conference

• Wednesday, February 29, 2012

  Alexion Joins EURORDIS, NORD and Patient Organizations Worldwide in Celebrating Rare Disease Day 2012

• Monday, February 27, 2012

  Alexion to Present at the Cowen and Company 32nd Annual Health Care Conference

• Friday, February 10, 2012

  Alexion to Present at the Leerink Swann 2012 Global Healthcare Conference

• Thursday, February 9, 2012

  Alexion Reports Fourth Quarter and Full Year 2011 Results

• Tuesday, February 7, 2012

  Alexion Completes Acquisition of Enobia Pharma Corp.

• Monday, January 30, 2012

  Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2011 Results on Thursday, February 9, 2012

• Tuesday, January 3, 2012

  Alexion to Present at the 30th Annual JP Morgan Healthcare Conference